English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

This paper aims to provide an initial assessment of the biopharmaceutical innovation system in Brazil by mapping the main linkages and actors that integrate such system and by analyzing the nature of the university-industry relationships established in crucial knowledge areas that support the biopharmaceutical research, development and innovation (RD&I) chain. The analysis is based upon data gathered from the Brazilian National Council for Scientific and Technological Development (CNPq) concerning the 20142016 period. 385 public and private laboratories operating in Brazil were identified and 27% of them established linkages with Brazilian Universities and Research Centers. Most of the university-industry collaborations regarded the conduction of basic and applied research in pharmacy, medicine, biochemistry and microbiology knowledge areas. FIOCRUZ, BUTANTAN, USP and UFRJ proved to be central institutions to the network structure. National and multinational companies displayed different patterns of interaction considering the types of relationship established and the knowledge areas involved.

Innovation and capabilities building in biopharmaceuticals in Brazil: a knowledge network analysis